O

Orion
ORNBV

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€9.78B
EV
€9.91B
Shares Outstanding
140.69M
Beta
0.38

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€68.70
P/E 2025E
23.06x
P/Revenue 2025E
5.45x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Orion Oyj

gainify

O

Orion Oyj

ORNBV

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products,...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Hurme, Liisa

Employees

3,700

IPO Date

2004-10-07

Headquarters

Orionintie 1A, Espoo, Uusimaa, 02200, Finland

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.